Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 97,847 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
doxorubicin
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs.
D V Unverferth, C V Leier, S P Balcerzak, R L Hamlin
Am J Cardiol
. Jul 01, 1985.56(1):157-61 Print
Source:PubMed
PMID:
4014022
doi:10.1016/0002-9149(85)90585-5
The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin.
Sarah N Hilmer, Victoria C Cogger, Michael Muller, David G Le Couteur
Drug Metab Dispos
. Aug, 2004.32(8):794-9 Print
Source:PubMed
PMID:
15258103
doi:10.1124/dmd.32.8.794
Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity.
A Kakuyama, Y Sadzuka
Curr Drug Metab
. Dec, 2001.2(4):379-95 Print
Source:PubMed
PMID:
11766989
doi:10.2174/1389200013338270
Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
A Rahman, D Carmichael, M Harris, J K Roh
Cancer Res
. May, 1986.46(5):2295-9 Print
Source:PubMed
PMID:
3697976
doi:
In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates.
Young Il Cho, Shinyoung Park, Seo Young Jeong, Hyuk Sang Yoo
Eur J Pharm Biopharm
. Sep, 2009.73(1):59-65 Print-Electronic
Source:PubMed
PMID:
19409990
doi:10.1016/j.ejpb.2009.04.010
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
F A Holmes, T Madden, R A Newman, V Valero, R L Theriault, G Fraschini, R S Walters, D J Booser, A U Buzdar, J Willey, G N Hortobagyi
J Clin Oncol
. Oct, 1996.14(10):2713-21 Print
Source:PubMed
PMID:
8874332
doi:10.1200/JCO.1996.14.10.2713
Pegylated liposomal doxorubicin in the treatment of breast cancer.
Joyce A O'Shaughnessy
Clin Breast Cancer
. Dec, 2003.4(5):318-28 Print
Source:PubMed
PMID:
14715106
doi:10.3816/cbc.2003.n.037
Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.
S Bennis, C Chapey, P Couvreur, J Robert
Eur J Cancer
. 1994.30A(1):89-93 Print
Source:PubMed
PMID:
8142172
doi:10.1016/s0959-8049(05)80025-5
Developmental toxicity of doxorubicin hydrochloride in embryo-larval stages of zebrafish.
Can Chang, Shao Ling Wu, Xin Dong Zhao, Chun Ting Zhao, Yan Hui Li
Biomed Mater Eng
. 2014.24(1):909-16 Print
Source:PubMed
PMID:
24211979
doi:10.3233/BME-130885
Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin.
Yuhuan Ji, Xueyuan Zhang, Jinzhi Liu, Yu Chen, Min Meng, ChunLei Li, Laixin Wang
J Pharm Biomed Anal
. Sep 10, 2020.189:113388 Print-Electronic
Source:PubMed
PMID:
32663760
doi:10.1016/j.jpba.2020.113388
0
Previous
Next